Nemolizumab pens for Belfast homecare patients come from Sciensus
- Belfast Health and Social Care Trust
- Northern Ireland
- Direct award
- 1 October 2026 to 30 September 2028
Belfast Health and Social Care Trust is buying nemolizumab from Sciensus Pharma Services Limited. The medicine comes in 30 mg pens, and Sciensus supplies it as a homecare service.
The trust awarded the contract directly to Sciensus in September 2026, without a competition. The two-year contract is worth £150,000 and runs to September 2028.
Contract ends September 2028
- What
- Homecare medicines services
- Supplier
- Sciensus Pharma Services Limited
- Value
- £150,000
- How it was bought
- Direct award
- Dates and next
- Oct 2026 to Sep 2028